Zadnji put ažurirano :
19/11/2024
protuupalni   Hydrocortisone  
oralna otopina
papirnata vrećica
Stabilnost farmaceutskih pripravaka Stabilnost mješavine Stabilizacijski faktor Kompatibilnosti Bibliografija pdf
   Kemijska struktura  

oralna otopina
Bibliografija   oralna otopina     Bibliografija : Hydrocortisone  
Vrsta Publikacija
909 Časopis Chong G, Decarie D, Ensom M.H.H.
Stability of hydrocortisone in extemporaneously compounded suspensions.
J Informed Pharmacother 2003 ; 13: 100-110.
2538 Časopis Fawcett JP, Boulton DW, Jiang R, Woods DJ.
Stability of hydrocortisone oral suspensions prepared from tablets and powder.
Ann Pharmacotherapy 1995 ;29:987-990.
2835 Časopis Das Gupta V.
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Int J Pharm Compound 2007 ; 11, 3: 259-261.
3755 Časopis Bourget P, Amin A, Vidal F, Pieyre M, Dosso E.O, Beauvais R, Loeuillet R.
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition.
Int J Pharm Compound 2014 ; 18, 5: 427-431.
3810 Časopis Geiger C M, Sorenson B, Whaley P.
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF.
Int J Pharm Compound 2015 ; 19, 5 : 420-427.
3811 Časopis Nahata Milap C.
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures.
Int J Pharm Compound 2015 ; 19, 5 : 428-431.
4063 Časopis Manchanda A, Laracy M, Savji T, Bogner R.
Stability of an Alcohol-free, Dye-free Hydrocortisone (2mg/mL) Compounded Oral Suspension.
Int J Pharm Compound 2018 ;22,1:66-75
4198 Časopis Uriel M, Gomez-Rincon C, Marro D.
Stability of regularly prescribed oral liquids formulated with SyrSpend® SF.
Pharmazie 2018 73;196-201
4530 Časopis Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R.
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt.
Int J Pharm Compound 2021 ;25,5:431-439

  Mentions Légales